Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2019 · first_quarter · Q1
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
Source: Senate LDA
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit. HR 1.H.R.1 - An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, sections pertaining to the Orphan Drug Tax Credit,
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. International Pricing Index. Reference pricing.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project.
Medicare Part B Improvement Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs.
Medicare IVIG Access Enhancement Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues.
Medicare Home Infusion Therapy Access Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit. HR 1.H.R.1 - An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, sections pertaining to the Orphan Drug Tax Credit,
Veterans Back to Work Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Veterans Back to Work Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Veterans Back to Work Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Veterans Back to Work Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
American Health Care Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Mortgage Fairness Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Mortgage Fairness Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Patients' Access to Treatments Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Patients' Access to Treatments Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Part B Home Infusion Services Temporary Transitional Payment Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Part B Improvement Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Part B Improvement Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Part B Improvement Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Safe Students Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Disaster Tax Relief and Airport and Airway Extension Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Disaster Tax Relief and Airport and Airway Extension Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Disaster Tax Relief and Airport and Airway Extension Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Home Infusion Therapy Access Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Home Infusion Therapy Access Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Medicare Home Infusion Therapy Access Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Agricultural Export Expansion Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Agricultural Export Expansion Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Agricultural Export Expansion Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Agricultural Export Expansion Act of 2017
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Patients' Access to Treatments Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Patients' Access to Treatments Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Medicare Home Infusion Site of Care Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Medicare Home Infusion Site of Care Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Medicare Home Infusion Site of Care Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Medicare Home Infusion Site of Care Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2018 · fourth_quarter · Q4
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. International Pricing Index. Reference pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2018 · third_quarter · Q3
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2018 · second_quarter · Q2
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2018 · first_quarter · Q1
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit. HR 1.H.R.1 - An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, sections pertaining to the Orphan Drug Tax Credit,
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · fourth_quarter · Q4
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · third_quarter · 3A
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · second_quarter · 2A
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · first_quarter · 1A
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · third_quarter · Q3
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · second_quarter · Q2
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.
HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2017 · first_quarter · Q1
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2016 · fourth_quarter · 4A
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via PLASMA PROTEIN THERAPEUTICS ASSOCIATION
2016 · fourth_quarter · Q4
HR 1600; SECTIONS RELATING TO SPECIALTY TIERS, HR 2570; RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S. 275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS RELATING TO HRSA AND 340B PROGRAM. HRSA NPRM RELATED TO PART B REIMBURSEMENT MODEL.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, S.275; SECTIONS RELATING TO COMPETITIVE BIDDING OF INFUSION PUMPS AND DRUGS, ISSUES RELATING TO ORPHAN DRUG DESIGNATIONS, FDA/OMNIBUS APPROPRIATIONS AND PROVISIONS RELATING TO PLASMA PROTEIN THERAPIES, AFFORDABLE CARE ACT, MEDICARE REIMBURSEMENT, COMMENTS SUBMITTED TO CMS AND HRSA RELATING TO HRSA AND 340B PROGRAM.HR 34, 21st Century Cures Act, sections relating to DME Competitive Bidding and Infusion Drugs
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit. HR 1.H.R.1 - An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, sections pertaining to the Orphan Drug Tax Credit,
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit.
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE